Antibiotics Targeted Therapies Repurposing Drugs Molecular Interactions Quantum Applications AI in Drug Development Chemical Reactions Clinical Trials AI in Healthcare Antimicrobial Agents Antimalarial Drugs Innovative Technologies Membrane Proteins Targeted Therapy Biotechnology Molecular Screening Antibiotic Resistance Personalized Medicine
Slated for delivery within two months, the SpiNNaker2 platform will underpin in-silico drug discovery at the University of Leipzig.